Inhibikase Therapeutics Inc IKT 價格預測與預測

Q: 技術分析指標如何適用於 IKT？

根據技術分析，Inhibikase Therapeutics Inc 的綜合信號為 Buy。Inhibikase Therapeutics Inc 有 3 個買入信號，2 個中性信號和 2 個賣出信號。

Q: IKT 的費波那契回檔水準是多少？

Inhibikase Therapeutics Inc 的費波那契回檔水準是 介於 0% 和 23.6% 之間。

Q: Inhibikase Therapeutics Inc 的 RSI 是多少？

Inhibikase Therapeutics Inc 的 RSI 目前為 53.23，表明處於 中立 狀態

Q: Inhibikase Therapeutics Inc 接下來 12 個月的價格是多少？

Inhibikase Therapeutics Inc IKT 接下來 12 個月的價格預估為 $6.12。

Q: Inhibikase Therapeutics Inc 預計會漲到多高？

據華爾街分析師稱，Inhibikase Therapeutics Inc 預計將達到 $8.4 的高預測值。

首頁

股票

IKT

預測

IKT 股票價格預測

Inhibikase Therapeutics Inc

$1.69

1.49%

$0.02

截至今日：Feb 17, 15:59:07 GMT-5

概觀預測收益股利財務狀況

關鍵數據

前收市價

$1.67

開盤價

$1.67

當日範圍

$1.65 - $1.72

52週區間

$1.33 - $3.32

交易量

460.2K

平均成交量

621.8K

每股盈餘 (TTM)

-1.15

股息收益率

市值

$204.9M

什麼是 IKT？

Inhibikase Therapeutics, Inc. is a clinical-stage pharmaceutical company, which engages in development of protein kinase inhibitor therapeutics to modify the course of Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. The company is headquartered in Wilmington, Delaware and currently employs 15 full-time employees. The company went IPO on 2020-12-23. The firm is focused on developing Abelson Tyrosine Kinase inhibitor therapeutics for cardiopulmonary disease. The Company’s multi-therapeutic pipeline includes IKT-001, a prodrug of imatinib mesylate, for pulmonary arterial hypertension (PAH).

功能特性

資源

市場

According to analyst forecasts, we anticipate notable price fluctuations for IKT in the upcoming periods. Looking toward the future, our 2027 projection indicates an average price target of $6.12. The lowest target is $3.03 and the highest is $8.4. Empower your investment choices with our cutting-edge, data-driven analysis!

IKT 股價預測摘要

IKT 的頂級分析師評級

根據 7 位分析師對 IKT 的股票評級，更新於 Sep 01, 2025

Buy

Strong buy

Buy

Hold

Sell

Strong sell

Leveraging in-depth analyst evaluations, we have synthesized key insights from expert assessments to present a positive outlook for IKT. Analysts highlight solid fundamentals and favorable market sentiment, suggesting upside potential in the near term. Based on this thorough expert analysis, we maintain an optimistic view of this stock. Our conclusion: IKT is a Buy candidate.

IKT stock price ended at $1.67 on 星期五, after rising 1.83%

On the latest trading day Feb 13, 2026, the stock price of IKT rose by 1.83%, climbing from $1.64 to $1.67. Throughout the session, the stock experienced a volatility of 5.49%, with prices fluctuating between a daily low of $1.64 and a high of $1.73. Alongside this price increase, trading volume also rose by 204.0K shares, reflecting strong market interest that may signal continued bullish momentum in the near term. In total, 225.7K shares were traded, amounting to a market value of approximately $201.9M.

IKT 技術面訊號

技術面訊號摘要

購買訊號 3

中性訊號 2

賣出訊號 2

Strong Sell

Sell

Neutral

Buy

Strong Buy

IKT 目前顯示 3 個買入訊號與 2 個賣出訊號。該股票自 12:00 AM 以來一直處於上升趨勢狀態，在此期間價格總共變動了 1.83%。整體而言，技術指標顯示中期後市趨勢為 Buy。

IKT 的看漲／看跌訊號

我們的演算法透過分析移動平均線、RSI、MACD 和成交量等關鍵指標，為IKT生成看漲和看跌訊號。這些見解可助您做出明智的投資決策。

後續問題

技術分析指標如何適用於 IKT？



IKT 的費波那契回檔水準是多少？



Inhibikase Therapeutics Inc 的 RSI 是多少？



Inhibikase Therapeutics Inc 接下來 12 個月的價格是多少？



Inhibikase Therapeutics Inc 預計會漲到多高？



Inhibikase Therapeutics Inc（IKT）價格

IKT 股價走勢圖